Company Analysis Atossa Therapeutics, Inc.
1. Summary
Advantages
- Price (0.64 $) is less than fair price (0.74 $)
- Current debt level 0.0013% is below 100% and has decreased over 5 years from 0.0421%.
Disadvantages
- Dividends (0%) are below the sector average (0.53%).
- The stock's return over the last year (-14.42%) is lower than the sector average (0%).
- The company's current efficiency (ROE=-31.39%) is lower than the sector average (ROE=104.34%)
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| Atossa Therapeutics, Inc. | Healthcare | Index | |
|---|---|---|---|
| 7 days | -1.5% | 0.3% | 0% |
| 90 days | -24.1% | -5.8% | 3.8% |
| 1 year | -14.4% | 0% | 21.3% |
ATOS vs Sector: Atossa Therapeutics, Inc. has significantly underperformed the "Healthcare" sector by -14.42% over the past year.
ATOS vs Market: Atossa Therapeutics, Inc. has significantly underperformed the market by -35.76% over the past year.
Stable price: ATOS is not significantly more volatile than the rest of the market on "NASDAQ" over the last 3 months, with typical variations of +/- 5% per week.
Long period: ATOS with weekly volatility of -0.28% over the past year.
3. Summary of the report
5. Fundamental Analysis
5.1. Stock price and price forecast
Below fair price: The current price (0.64 $) is lower than the fair price (0.74 $).
Price not significantly lower than the fair price: The current price (0.64 $) is slightly lower than the fair price by 15.6%.
5.2. P/E
P/E vs Sector: The company's P/E (-3.88) is lower than that of the sector as a whole (35.84).
P/E vs Market: The company's P/E (-3.88) is higher than that of the market as a whole (-65.92).
5.3. P/BV
P/BV vs Sector: The company's P/BV (1.72) is lower than that of the sector as a whole (254.49).
P/BV vs Market: The company's P/BV (1.72) is lower than that of the market as a whole (51.09).
5.3.1 P/BV Similar companies
5.5. P/S
P/S vs Sector: The company's P/S indicator (0) is lower than that of the sector as a whole (127.81).
P/S vs Market: The company's P/S indicator (0) is lower than that of the market as a whole (147.92).
5.5.1 P/S Similar companies
5.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (-2.02) is higher than that of the sector as a whole (-27.35).
EV/Ebitda vs Market: The company's EV/Ebitda (-2.02) is higher than that of the market as a whole (-94.27).
6. Profitability
6.1. Profitability and revenue
6.2. Earnings per share - EPS
6.3. Past profitability Net Income
Yield Trend: Rising and has grown by 4.29% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (4.29%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-1802.65%).
6.4. ROE
ROE vs Sector: The company's ROE (-31.39%) is lower than that of the sector as a whole (104.34%).
ROE vs Market: The company's ROE (-31.39%) is lower than that of the market as a whole (-6.17%).
6.6. ROA
ROA vs Sector: The company's ROA (-29.54%) is lower than that of the sector as a whole (-2.2%).
ROA vs Market: The company's ROA (-29.54%) is lower than that of the market as a whole (38.35%).
6.6. ROIC
ROIC vs Sector: The company's ROIC (-15.9%) is lower than that of the sector as a whole (1.17%).
ROIC vs Market: The company's ROIC (-15.9%) is lower than that of the market as a whole (9.59%).
8. Dividends
8.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '0.53%.
8.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
8.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
Based on sources: porti.ru
